lanternpharma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Lantern Pharma Inc - Precision Oncology |
| Description | Transforming Oncology Drug Lantern Pharma is an oncology-focused, emerging, clinical stage pharma leveraging Artificial Intelligence, Genomics, and Machine Learning to transform the cost, pace, and timeline of drug discovery and |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 99.83.190.102 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
lanternpharma.com Valuation
|
US$10,037,701
Last updated: 2023-04-28 22:39:37
lanternpharma.com has Semrush global rank of 1,054,455. lanternpharma.com has an estimated worth of US$ 10,037,701, based on its estimated Ads revenue. lanternpharma.com receives approximately 1,158,197 unique visitors each day. Its web server is located in United States, with IP address 99.83.190.102. According to SiteAdvisor, lanternpharma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$10,037,701 |
| Daily Ads Revenue | US$9,266 |
| Monthly Ads Revenue | US$277,968 |
| Yearly Ads Revenue | US$3,335,605 |
| Daily Unique Visitors | 77,214 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| lanternpharma.com. | A | 3599 | IP: 99.83.190.102 |
| lanternpharma.com. | A | 3599 | IP: 75.2.70.75 |
| lanternpharma.com. | NS | 3600 | NS Record: ns63.domaincontrol.com. |
| lanternpharma.com. | NS | 3600 | NS Record: ns64.domaincontrol.com. |
| lanternpharma.com. | MX | 3600 | MX Record: 5 alt1.aspmx.l.google.com. |
| lanternpharma.com. | MX | 3600 | MX Record: 5 alt2.aspmx.l.google.com. |
| lanternpharma.com. | MX | 3600 | MX Record: 10 aspmx2.googlemail.com. |
| lanternpharma.com. | MX | 3600 | MX Record: 10 aspmx3.googlemail.com. |
| lanternpharma.com. | MX | 3600 | MX Record: 1 aspmx.l.google.com. |
| lanternpharma.com. | TXT | 3600 | TXT Record: google-site-verification=F5gcQ8y6RjSKwHwHSsdOo4q-IJEDxEONi5Gwo6mPGls |
| lanternpharma.com. | TXT | 3600 | TXT Record: google-site-verification=vI29uydKYPgsxLmSKd05sywHPA0KnXwV15r563Emvx4 |
| lanternpharma.com. | TXT | 3600 | TXT Record: google-site-verification=CMarqruLK1G6vhUxSxnKrEWocTbXknLpCl1L5TohUrk |
| lanternpharma.com. | TXT | 3600 | TXT Record: google-site-verification=-ZmwV6OPQ0l1HpOU7uxGAw3xUKxVcaAPPGPSLdEYU5M |
| lanternpharma.com. | TXT | 3600 | TXT Record: v=spf1 +mx +a +ip4:64.91.247.132 ~all |
HtmlToTextCheckTime:2023-04-28 22:39:37
| INVESTORS Overview Fact Sheet Analyst Coverage Corporate Presentations Recent Filings Stock Price Home Investors Contact About Welcome Mission Partnering Patents A.I. Platform Our Technology RADR ® Collaborations Pipeline Overview LP300 | LP100 | LP184 | LP284 |ADC Program Clinical Trials Compassionate Use Publications Posters TEAM Leadership Board of Directors Advisors Lantern Careers MEDIA News Podcasts Press Social Media Newsletter Videos Webinars Contact Investors Transforming Oncology Drug Development Lantern Pharma is leveraging A.I., machine learning & genomics to transform the cost, pace, and timeline of oncology drug discovery and development See how we are doing it 01 02 03 A Pioneering & World Class Team Dedicated to Creating Novel & Breakthrough Precision Oncology Therapies Conquering cancer requires bringing unique talents & individuals together for the advancement of patient care Meet our team 01 02 03 Transforming Oncology Drug Development Lantern Pharma is leveraging |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: openresty Date: Thu, 21 Oct 2021 21:34:01 GMT Content-Type: text/html Content-Length: 166 Connection: keep-alive Location: https://lanternpharma.com/ HTTP/2 301 server: openresty date: Thu, 21 Oct 2021 21:34:01 GMT content-type: text/html content-length: 166 location: https://www.lanternpharma.com/ HTTP/2 200 server: openresty date: Thu, 21 Oct 2021 21:34:01 GMT content-type: text/html content-length: 60244 content-security-policy: frame-ancestors 'self' x-frame-options: SAMEORIGIN x-lambda-id: 1180db90-d58d-4d5f-a658-143e1a119a9b via: 1.1 varnish, 1.1 varnish accept-ranges: bytes age: 77889 x-served-by: cache-dca17782-DCA, cache-wdc5525-WDC x-cache: HIT, HIT x-cache-hits: 1, 1 x-timer: S1634852042.774528,VS0,VE1 vary: Accept-Encoding x-cluster-name: us-east-1-prod-edge-eks-15 |
lanternpharma.com Whois Information
Domain Name: LANTERNPHARMA.COM Registry Domain ID: 1830657104_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2019-06-04T20:43:30Z Creation Date: 2013-10-10T18:41:54Z Registry Expiry Date: 2029-05-13T11:59:59Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS63.DOMAINCONTROL.COM Name Server: NS64.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-10T16:32:50Z <<< |